Recent SEC filings
Insider and ownership filing tracker
Form 4 reports insider transactions. Schedule 13D and 13G filings report certain significant ownership positions. 13F reports institutional holdings when filed by an investment manager. Always open the original filing for context.
Company and financial overview
This is a data-generated overview, not a published Rithvik Chethan research rating. Figures use the latest usable company filing and may differ from vendor-calculated trailing metrics.
Financial performance charts
Annual values from SEC filings. Free cash flow is calculated as operating cash flow less capital expenditures.
Upcoming catalyst timeline
Review the Earnings tab for the expected date and estimates.
PRIMARY DOCUMENT
EMA, RSI, MACD, volume, structure, and key levels update after a completed daily candle.
How the research score works
The overall score is a weighted research judgment covering business quality, fundamental strength, growth catalysts, valuation, technical condition, and downside risk. A high score does not eliminate risk, and a low score does not guarantee poor performance.
Company overview
Intuitive Surgical develops and manufactures robotic assisted surgical systems, best known for its da Vinci surgical platform used across a wide range of minimally invasive surgical procedures globally.
Business model
The company earns revenue from initial system sales along with highly recurring revenue from instruments, accessories, and service contracts tied to its large and growing installed base of surgical robots, a razor and blade style business model.
Growth drivers
- Continued procedure volume growth on installed systems
- New system placements expanding the installed base
- International market expansion
- New surgical procedure categories adopting robotic assistance
Competitive position
Intuitive Surgical's decades long first mover advantage, extensive surgeon training infrastructure, and large installed base create substantial switching costs that have made it difficult for newer robotic surgery competitors to gain meaningful share.
Risks
Increasing competition from newer robotic surgery entrants could eventually pressure its dominant market position, healthcare capital spending cycles affect new system placements, and reimbursement policy changes could affect procedure economics.
Valuation
Intuitive Surgical trades at a premium valuation typical of high quality medical device leaders, reflecting its recurring revenue model, high margins, and historically consistent procedure volume growth.
Final view
Intuitive Surgical's dominant position in robotic surgery and highly recurring revenue model make it one of the higher quality names in medical devices. My view is favorable, with emerging robotic surgery competition being the primary long term risk to track.
Overall rating: 80/100
This website and its analysis are provided for educational and informational purposes only. Nothing on this site constitutes financial, investment, legal, or tax advice, or an offer to buy or sell any security. Market data is provided by Finnhub and other third-party sources and may be delayed, incomplete, or inaccurate. The author may hold positions in securities discussed, and opinions may change without notice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial professional before making investment decisions.